QuidelOrtho Corporation/QDEL

$46.80

2.02%
-
1D1W1MYTD1YMAX

About QuidelOrtho Corporation

QuidelOrtho Corporation is a vitro diagnostics company. The Company is engaged in the development and manufacturing of advanced technologies in diagnostic testing. Its capabilities include immunoassay and molecular testing, clinical chemistry and transfusion medicine. The Company’s business units include Labs, Molecular Diagnostics, Point of Care, and Transfusion Medicine. Its Labs business unit includes Virology, Specialty Products, Specialty Products, Immunodiagnostics, VITROS Platform, XT Platform, VITROS XT Platform, and VITROS Automation Solutions. Its Molecular Diagnostics business includes Lyra, Solana, and Savanna. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, D, ELVIRA, ELVIS, FastPoint, FreshCells, InflammaDry, Lyra, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Vision, Quidel, QuickVue, QuickVue+, QVue, ReadyCells, Savanna, Sofia, Solana, Thyretain, Triage, Virena, and Vitros.

Ticker

QDEL

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Michael Iskra

Employees

7,000

Headquarters

San diego, United States

QDEL Metrics

BasicAdvanced
$3.13B
Market cap
-
P/E ratio
-$0.15
EPS
0.12
Beta
-
Dividend rate

What the Analysts think about QDEL

Analyst Ratings

Majority rating from 8 analysts.
Hold

Price Targets

Average projection from 6 analysts.
79.85% upside
High $158.00
Low $50.00
$46.80
Current price
$84.17
Average price target

QDEL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.94% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$742.6M
-0.19%
Net income
$7M
-155.12%
Profit margin
0.94%
-155.29%

QDEL Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 42.87%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.80
$0.26
$0.90
$1.17
-
Expected
$1.49
$0.28
$0.60
$2.05
$0.70
Surprise
20.6%
-6.98%
50.75%
-42.87%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell QuidelOrtho Corporation stock

Buy or sell QuidelOrtho Corporation stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing